home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Genenta Science S.p.A. - American Depositary Shares (NQ:GNTA)

2.040 +0.080 (+4.08%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Genenta Science S.p.A. - American Depositary Shares

< Previous 1 2 3 4 Next >

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

October 02, 2024

Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2

From GENENTA SCIENCE SPA

Via GlobeNewswire

7 Penny Biotech Stocks to Triple Your Investment ↗

May 28, 2024

Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.

Via InvestorPlace

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

May 06, 2024

From GENENTA SCIENCE SPA

Via GlobeNewswire

This Small Cap Cancer Company 'Hijacks Tumors From Within," HC Wainwright Says ↗

July 25, 2022

Via Benzinga

Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference

March 01, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 12, 2024

Via Benzinga

Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors

February 08, 2024

Based on Preliminary Data from Ongoing Dose Ranging Stage of the Phase 1/2 Clinical Trial

From GENENTA SCIENCE SPA

Via GlobeNewswire

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 22, 2023

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Via Benzinga

Genenta to Present at Upcoming Scientific and Investor Conferences

September 06, 2023

From GENENTA SCIENCE SPA

Via GlobeNewswire

Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments

July 28, 2023

Company Selects Refractory Advanced Genitourinary Malignancies including Renal Cell Cancer as Second Indication

From GENENTA SCIENCE SPA

Via GlobeNewswire

The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma

June 29, 2023

From GENENTA SCIENCE SPA

Via GlobeNewswire

Genenta to Provide Update on Lead Product Temferon™

May 16, 2023

Prof. Luigi Naldini will present updates on the efficacy of Temferon in pre-clinical solid tumor models and preliminary clinical biological data confirming in patients

From GENENTA SCIENCE SPA

Via GlobeNewswire

Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing

April 26, 2023

From GENENTA SCIENCE SPA

Via GlobeNewswire

Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 35th Annual Roth Conference

February 22, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 14, 2023

Via Benzinga

Genenta Sciences (NASDAQ: GNTA) Featured in Virtual Coverage of Roth’s Healthcare Opportunities Conference

September 29, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 16, 2022

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022 ↗

July 25, 2022

Upgrades

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 28, 2022

Gainers

Via Benzinga

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

September 08, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

Via Benzinga

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗

June 29, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 23, 2022

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Genenta Science (NASDAQ: GNTA) Featured in Virtual Coverage of the 34th Annual Roth Conference

March 07, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 03, 2022

Gainers Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 49.1% to $0.28 during Thursday's regular session. As of 12:31 EST, Tonix Pharmaceuticals's stock is trading...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com